Anthem Biosciences Ltd.
Anthem Biosciences Ltd. (ANTHEM.NS) Stock Overview
Explore Anthem Biosciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
371.2B
P/E Ratio
76.57
EPS (TTM)
$8.59
ROE
0.19%
ANTHEM.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Anthem Biosciences Ltd. (ANTHEM.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $619.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 76.57 and a market capitalization of 371.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.